Sally Wetten, MA

GSK
Bicester, United Kingdom

Experienced industry epidemiologist providing real-world evidence expertise and collaborative leadership to cross-functional teams across drug discovery, development and post-approval stages to enhance the regulatory and commercial success of assets

Presentation(s):

• 0169: The High Disease Burden of Connective Tissue Disorder-Interstitial Lung Disease in the USA Demonstrates an Unmet Need for Earlier Diagnosis and Treatment

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): GlaxoSmithKlein(GSK): Employee (Ongoing)